Rxsight, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Rxsight, Inc. on June 2, 2022, to disclose the results of its Annual Meeting of Stockholders held on the same date. The company is incorporated in Delaware and its common stock trades on The NASDAQ Stock Market LLC under the symbol "RXST."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
Of the 27,485,685 shares of common stock outstanding as of April 11, 2022, 22,696,297 shares (approximately 82.6%) were represented at the meeting. The following matters were voted upon:
- Election of Class I Directors: Three nominees were re-elected to serve until the 2025 annual meeting.
- Ron Kurtz, M.D.: 18,528,187 votes For; 469,340 Abstain; 3,698,770 Broker Non-Votes.
- J. Andy Corley: 18,347,658 votes For; 649,869 Abstain; 3,698,770 Broker Non-Votes.
- Juliet Tammenoms Bakker: 18,504,860 votes For; 492,667 Abstain; 3,698,770 Broker Non-Votes.
- Ratification of Independent Auditor: The appointment of Ernst & Young LLP for the fiscal year ending December 31, 2022, was ratified.
- Votes: 22,575,352 For; 2,827 Against; 118,118 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the re-election of the three Class I directors and their tenure through 2025.
- Confirm the ratification of Ernst & Young LLP as the independent auditor for fiscal year 2022.
- Note the high level of shareholder participation (82.6%) and the significant number of broker non-votes (3,698,770) regarding director elections.
- Review subsequent filings (e.g., 10-K or 10-Q) for financial performance data, as this 8-K contains no financial metrics.